REGN - Small Cancer Therapy Player Celularity To Provide Research Support For Regeneron's Therapy | Benzinga
Celularity Inc (NASDAQ: CELU) shares are trading higher after the company announced a multi-year Research Collaboration Services Agreement with Regeneron Pharmaceuticals Inc (NASDAQ: REGN).
The pact supports the research of Regeneron's allogeneic cell therapy candidates.
The ...